August 31st, 2010
ESC: The Good, the Bad, and the Better
Susan Cheng, MD
As far as conferences go, I’m impressed. It’s only day two for me, but I can already say that I would come back. The workshops and clinical sessions are solid. The original science being presented is plentiful and of good quality. One Austrian colleague mentioned he was particularly pleased with the growth of basic science […]
August 29th, 2010
ESC First Impressions: Size Matters
Susan Cheng, MD
I’ll admit I was a bit guarded about my first ESC conference, largely due to what seemed to be looming logistical issues. Despite all of Stockholm’s reported charm, it was hard to imagine how a city of this size was going to manage the invasion of over 20,000 — and possibly up to 30,000 — […]
NEJM Journal Watch — Recent Cardiology Articles- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy
- Does Colchicine Reduce Cardiac Events After Myocardial Infarction?
- First-Line Therapy for Ventricular Tachycardia After MI: What's the Best Approach?